Trevi Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Trevi Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Trevi Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Trevi Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.2M | 788k | 9.15 |
| 2025-03-31 | $1.3M | 212k | 6.29 |
| 2024-12-31 | $973k | 236k | 4.12 |
| 2024-09-30 | $549k | 164k | 3.34 |
| 2024-06-30 | $218k | 73k | 2.98 |
| 2024-03-31 | $131k | 38k | 3.45 |
| 2023-12-31 | $32k | 24k | 1.34 |
| 2023-09-30 | $57k | 26k | 2.18 |
| 2023-06-30 | $84k | 35k | 2.39 |